ArticleFrontiers in oncology2022

The value of combined PET/MRI, CT and clinical metabolic parameters in differentiating lung adenocarcinoma from squamous cell carcinoma.

Xin Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.